Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Human Biospecimen & Anatomical Substance Acquisition

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract with the Defense Health Agency Contracting Activity involves the acquisition and management of human anatomical substances and biospecimens to support research projects. The selected provider is responsible for recruiting military and Veteran populations, collecting samples, and maintaining secure storage. Key deliverables include the provision of human anatomical samples and the associated patient data necessary for research objectives. The project requires strict adherence to human subjects research laws and the procurement of necessary IRB approvals. This opportunity, categorized under NAICS code 621511, was posted on August 26, 2026, with a response deadline of November 4, 2026.

General Info

DHA subcontract for recruiting, collecting, and managing human biospecimens for research projects.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of HT942526RTRPIIRA.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Reconstructive Transplant, Investigator-Initiated Research Award

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies human anatomical substances and manages biospecimen acquisition for prime contractors on Defense Health Agency research projects. Recruits military and Veteran populations, collects samples, and manages secure storage. Requires IRB approval and compliance with human subjects research laws. Delivers human anatomical samples and associated patient data.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
New
Grant
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Solicitation # HT942526BCRPBTA122
The Department of Defense, through the Defense Health Agency Contracting Activity, is soliciting applications for the Fiscal Year 2026 Breast Cancer Research Program Breakthrough Award Levels 1 and 2 under solicitation number HT942526BCRPBTA122. This mechanism is designed to support high-potential research aimed at achieving breakthroughs in breast cancer, requiring all applications to address at least one overarching FY26 BCRP challenge or provide a strong justification for an exception. The program offers two funding levels with distinct research scopes, including a Population Science Studies option under Level 2 that may allow for increased funding and an extended period of performance. Eligible applicants may apply as a single Principal Investigator or through a partnering arrangement involving an Initiating PI and a Partnering PI. The application process follows a two-step sequence, with pre-applications due by November 4, 2026, and full applications due by November 18, 2026. For those utilizing the Partnering PI Option, both investigators must submit full applications to avoid administrative withdrawal. The program emphasizes a focus on research that can lead to clinical application and major impact, with all submissions governed by specific registration and review criteria managed by the grantor.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 2 months
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS